Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Strategies to counter antipsychotic-associated weight gain in patients with schizophrenia
Wade Marteene, Karl Winckel, Samantha Hollingworth, et al.
Expert Opinion on Drug Safety (2019) Vol. 18, Iss. 12, pp. 1149-1160
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Cardiovascular disease in patients with severe mental illness
René Ernst Nielsen, Jytte Banner, Svend Eggert Jensen
Nature Reviews Cardiology (2020) Vol. 18, Iss. 2, pp. 136-145
Closed Access | Times Cited: 263
Semaglutide for the treatment of antipsychotic-associated weight gain in patients not responding to metformin – a case series
Femin Prasad, Riddhita De, Vittal Korann, et al.
Therapeutic Advances in Psychopharmacology (2023) Vol. 13
Open Access | Times Cited: 54
The Burden of Antipsychotic-Induced Weight Gain and Metabolic Syndrome in Children
Mark R. Libowitz, Erika L. Nurmi
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 61
Antipsychotic-Induced Weight Gain in Severe Mental Illness: Risk Factors and Special Considerations
Nicolette Stogios, Bailey Humber, Sri Mahavir Agarwal, et al.
Current Psychiatry Reports (2023) Vol. 25, Iss. 11, pp. 707-721
Closed Access | Times Cited: 32
Pharmacological Management of Glucose Dysregulation in Patients Treated with Second-Generation Antipsychotics
Simona Cernea, Lorena Dima, Christoph U. Correll, et al.
Drugs (2020) Vol. 80, Iss. 17, pp. 1763-1781
Closed Access | Times Cited: 53
Nose-to-brain delivery of antipsychotics using nanotechnology: a review
Madeleine S. A. Tan, Harendra S. Parekh, Preeti Pandey, et al.
Expert Opinion on Drug Delivery (2020) Vol. 17, Iss. 6, pp. 839-853
Closed Access | Times Cited: 52
Interactions between Food and Drugs, and Nutritional Status in Renal Patients: A Narrative Review
Claudia D’Alessandro, Alessia Benedetti, Antonello Di Paolo, et al.
Nutrients (2022) Vol. 14, Iss. 1, pp. 212-212
Open Access | Times Cited: 30
Association between antipsychotic medication and clinically relevant weight change: meta-analysis
Bea Campforts, Marjan Drukker, Joost Crins, et al.
BJPsych Open (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 18
GLP-1 receptor agonists and weight loss in schizophrenia – past, present, and future
Mike Trott, Urška Arnautovska, Dan Siskind
Current Opinion in Psychiatry (2024) Vol. 37, Iss. 5, pp. 363-369
Closed Access | Times Cited: 6
Does Switching Antipsychotics Ameliorate Weight Gain in Patients With Severe Mental Illness? A Systematic Review and Meta-analysis
Dan Siskind, Erin Gallagher, Karl Winckel, et al.
Schizophrenia Bulletin (2020) Vol. 47, Iss. 4, pp. 948-958
Open Access | Times Cited: 43
A systematic review and meta-analysis of the association between clozapine and norclozapine serum levels and peripheral adverse drug reactions
Madeleine S. A. Tan, Faraz Honarparvar, James R. Falconer, et al.
Psychopharmacology (2021) Vol. 238, Iss. 3, pp. 615-637
Closed Access | Times Cited: 40
Antipsychotics result in more weight gain in antipsychotic naive patients than in patients after antipsychotic switch and weight gain is irrespective of psychiatric diagnosis: A meta-analysis
Maarten Bak, Marjan Drukker, Shauna Cortenraad, et al.
PLoS ONE (2021) Vol. 16, Iss. 2, pp. e0244944-e0244944
Open Access | Times Cited: 40
Antipsychotic-Induced Metabolic Syndrome: A Review
Samuel Akinola, Isabelle Tardif, Jacinthe Leclerc
Metabolic Syndrome and Related Disorders (2023) Vol. 21, Iss. 6, pp. 294-305
Closed Access | Times Cited: 14
Risk factors, prevention and treatment of weight gain associated with the use of antidepressants and antipsychotics: a state-of-the-art clinical review
Marco Solmi, Alessandro Miola, Federico Capone, et al.
Expert Opinion on Drug Safety (2024) Vol. 23, Iss. 10, pp. 1249-1269
Closed Access | Times Cited: 5
Physical Health in Psychosis: a Perspective on the Recovery Paradigm
Anna Zierotin, Michael John Norton, Brian O’Donoghue, et al.
Irish Journal of Psychological Medicine (2025), pp. 1-7
Closed Access
INTEGRATE: international guidelines for the algorithmic treatment of schizophrenia
Robert A. McCutcheon, Toby Pillinger, Ioana Varvari, et al.
The Lancet Psychiatry (2025)
Closed Access
Approaches to mitigate weight gain associated with antipsychotic use
Florian Tran, Allan J. Barnes, Rebecca Urbonas, et al.
Personalized Medicine in Psychiatry (2025) Vol. 51-52, pp. 100151-100151
Closed Access
Latest findings challenge behavioural approaches to the management of antipsychotic-induced weight gain
Steve Kisely, Dan Siskind, Helene Speyer
BJPsych Open (2025) Vol. 11, Iss. 3
Open Access
Longitudinal Gut Microbiota Dysbiosis Underlies Olanzapine-Induced Weight Gain
豊田 隆謙, Xiaoyan He, Y. Liu, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 4
Open Access | Times Cited: 10
Does the gut microbiome mediate antipsychotic-induced metabolic side effects in schizophrenia?
Svetlina Vasileva, J. Tucker, Dan Siskind, et al.
Expert Opinion on Drug Safety (2022) Vol. 21, Iss. 5, pp. 625-639
Closed Access | Times Cited: 15
Is Clozapine-induced Weight Gain Dose-dependent? Results From a Prospective Cohort Study
Marianna Piras, Jihane Chahma, Setareh Ranjbar, et al.
Schizophrenia Bulletin (2023) Vol. 49, Iss. 4, pp. 944-952
Open Access | Times Cited: 8
Differential Effects of Acute Treatment With Antipsychotic Drugs on Peripheral Catecholamines
Heidi N. Boyda, Amanzo A. Ho, Lurdes Tse, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 22
Effect of Quetiapine, from Low to High Dose, on Weight and Metabolic Traits: Results from a Prospective Cohort Study
Céline Dubath, Marianna Piras, Mehdi Gholam, et al.
Pharmacopsychiatry (2021) Vol. 54, Iss. 06, pp. 279-286
Open Access | Times Cited: 18
Social isolation triggers oxidative status and impairs systemic and hepatic insulin sensitivity in normoglycemic rats
María Bové, Adriano Lama, Stefania Schiavone, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 149, pp. 112820-112820
Open Access | Times Cited: 13
Metformin for the prevention of clozapine‐induced weight gain: A retrospective naturalistic cohort study
Nicolette Stogios, Kateryna Maksyutynska, Janani Navagnanavel, et al.
Acta Psychiatrica Scandinavica (2022) Vol. 146, Iss. 3, pp. 190-200
Closed Access | Times Cited: 13
Page 1 - Next Page

Scroll to top